VK2735 for Weight Management Phase 2 (Venture Oral Dosing)
Clinical trial NCT06828055 · COMPLETED
Trial details
- NCT number
- NCT06828055
- Sponsor
- Viking Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-18
- Primary completion
- 2025-06-24
- Enrollment
- 280
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.